Notice: Function _load_textdomain_just_in_time was called incorrectly. Translation loading for the wordpress-seo domain was triggered too early. This is usually an indicator for some code in the plugin or theme running too early. Translations should be loaded at the init action or later. Please see Debugging in WordPress for more information. (This message was added in version 6.7.0.) in /var/www/html/wp-includes/functions.php on line 6260 Avista Pharma Completes Durham HQ Expansion | Contract Pharma

What are you searching for?

Sign in
Breaking News

Avista Pharma Completes Durham HQ Expansion

Analytical Research and Development and Quality Control labs have doubled in size and expanded service offerings

Author Image

By: Kristin Brooks

Managing Editor, Contract Pharma

Avista Pharma Solutions, Inc. has completed the expansion and upgrades to its Analytical Laboratories at its Durham, NC facility. The investment significantly increases capacity as well as a range of capabilities for its pharmaceutical and medical device clients.
 
The Analytical Research and Development (ARD) and Quality Control (QC) labs have doubled in size and expanded the service offerings. The completed Analytical Laboratories’ systems and equipment include a Thermo Scientific Orbitrap High-Resolution Mass Spectrometer, Mass-Directed Preparative Chromatography, Agilent UPLC-tandem Quad MS, Waters H-class UPLCs with six-column switching capabilities and PDA/ELSD/CAD/Single Quad MS detectors, along with upgraded Laboratory Information Management System (LIMS), Empower 3 Chromatography Data Software and Agilent MassHunter software with Enterprise Content Manager.
 
“Expanding our laboratory and adding new service offerings reinforces our commitment to providing our clients with a world-class center of excellence to assist in their product development efforts,” said Patrick Walsh, chief executive officer at Avista. “Our clients choose to work with us because our skilled teams are relentless in support of their project needs.”
 
Avista’s full-service offering includes: Chromatographic method development for assay and related substances, potential genotoxic impurities, organic volatile impurities and residual solvents; Spectral identification using upgraded FTIR, NMR and UV-Vis instrumentation; Structural chemistry and impurity identification through accurate mass LC-MS and generation fragmentation (MSn), 1D and 2D NMR and preparative chromatography isolation; Fate and purge studies; Extractable/leachable studies; Release and stability testing.

Add us as a preferred source on Google

Get the latest Contract Pharma news, insights and analysis in your Google Search and AI experiences.

Add Contract Pharma as a preferred source on Google (opens in a new tab)

Keep Up With Our Content. Subscribe To Contract Pharma Newsletters

Topics